Chemoinformaics analysis of BUTYL ISOVALERATE
Molecular Weight | 158.241 | nRot | 5 |
Heavy Atom Molecular Weight | 140.097 | nRig | 1 |
Exact Molecular Weight | 158.131 | nRing | 0 |
Solubility: LogS | -3.215 | nHRing | 0 |
Solubility: LogP | 3.201 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 29 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 28.6363 |
nHD | 0 | BPOL | 20.6617 |
QED | 0.453 |
Synth | 1.83 |
Natural Product Likeliness | 0.286 |
NR-PPAR-gamma | 0.004 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.01 |
Pgp-sub | 0.001 |
HIA | 0.002 |
CACO-2 | -4.226 |
MDCK | 0.0000323 |
BBB | 0.959 |
PPB | 0.745975 |
VDSS | 0.683 |
FU | 0.306824 |
CYP1A2-inh | 0.962 |
CYP1A2-sub | 0.241 |
CYP2c19-inh | 0.672 |
CYP2c19-sub | 0.677 |
CYP2c9-inh | 0.55 |
CYP2c9-sub | 0.596 |
CYP2d6-inh | 0.01 |
CYP2d6-sub | 0.105 |
CYP3a4-inh | 0.049 |
CYP3a4-sub | 0.224 |
CL | 13.106 |
T12 | 0.79 |
hERG | 0.031 |
Ames | 0.006 |
ROA | 0.073 |
SkinSen | 0.838 |
Carcinogencity | 0.241 |
EI | 0.988 |
Respiratory | 0.122 |
NR-Aromatase | 0.004 |
Antiviral | No |
Prediction | 0.94798 |